Vaccination Phase 2
- All
- News
- Videos
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
Dr Reddy's Hopes To Submit Sputnik V Light Trial Data To Drug Regulator In November
Dr Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month, even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18
-
Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the DCGI, Chairman and Managing Director of Bharat Biotech, Krishna Ella said.
-
South Africa Vaccinates 2,000 Children In Trial Of Chinese Vaccine
South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.
-
Recruitment Of Volunteers For Trial Of Covovax Vaccine On Children Begins
Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine Covovax among children aged 2 to 17 years began on Sunday at the Hamdard Institute of Medical Sciences and Research In Delhi.
-
Bharat Biotech's 1st Nasal Covid Vaccine Gets Phase 2/3 Trial Nod
BBV154, developed by Bharat Biotech, is India's first intranasal vaccine to receive regulatory nod for late-stage clinical trials from the Biotechnology Industry Research Assistance Council's (BIRAC) under the Department of Biotechnology.
-
Panel Recommends Nod To Serum Institute For Covid Jab Trials On Children
An expert panel of the Central Drugs Standard Control Organisation today recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covovax on children aged 2 to 17 years with certain conditions, sources said
-
BJP's New Plan To Shake Off COVID-19 Criticism
The BJP is set to start the second phase of a countrywide voluntary service to promote Covid vaccination, promote awareness and help people affected with the disease.
-
Covaxin Phase 2, 3 Clinical Trials For 2-18 Age Group Cleared
Covaxin trials on children from two to 18 years were cleared by the Drugs Controller General of India (DCGI) today. This is the first time in India that a Covid vaccine will be tested on children.
-
5 States, Union Territories Have No Private Facility For Covid Vaccine: Government Data
With the 3rd phase of COVID-19 vaccination opening in less than 2 weeks for everyone above 18, largely via private facilities, data shows almost all small states and union territories are still entirely or mostly dependent on government facilities.
-
Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report
Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
-
Covaxin Safe, Phase 3 Results Needed To Assess Effectiveness, Says Lancet
Covaxin, the homegrown coronavirus vaccine that was authorized for use in January before full clinical trial data, has been declared "safe, immunogenic with no serious side effects" by Lancet that has published its phase 2 results.
-
Getting A Covaxin Or Covishield Shot? List Of Possible Mild Side Effects
Phase 2 of the vaccination drive against the coronavirus - in which people aged above 60 and those above 45 with comorbidities are being inoculated - began on Monday.
-
Over 1 Million Registrations On CoWin For Phase 2 Vaccinations: 10 Points
Over a million people had registered on the government's CoWin portal by 1 pm today to get vaccinated against the coronavirus in the second phase of the country's inoculation drive. While the first phase of the vaccination campaign targeted healthcare and other frontline workers, the second phase that began today aims to inoculate those above 60 ye...
-
Odisha, Bihar Chief Ministers Take Vaccine Shots As India Begins Phase 2
Chief Ministers of Odisha and Bihar were among the beneficiaries as the second phase of the nationwide Covid vaccination began with Prime Minister Narendra Modi as the first beneficiary.
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
Dr Reddy's Hopes To Submit Sputnik V Light Trial Data To Drug Regulator In November
Dr Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month, even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18
-
Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the DCGI, Chairman and Managing Director of Bharat Biotech, Krishna Ella said.
-
South Africa Vaccinates 2,000 Children In Trial Of Chinese Vaccine
South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.
-
Recruitment Of Volunteers For Trial Of Covovax Vaccine On Children Begins
Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine Covovax among children aged 2 to 17 years began on Sunday at the Hamdard Institute of Medical Sciences and Research In Delhi.
-
Bharat Biotech's 1st Nasal Covid Vaccine Gets Phase 2/3 Trial Nod
BBV154, developed by Bharat Biotech, is India's first intranasal vaccine to receive regulatory nod for late-stage clinical trials from the Biotechnology Industry Research Assistance Council's (BIRAC) under the Department of Biotechnology.
-
Panel Recommends Nod To Serum Institute For Covid Jab Trials On Children
An expert panel of the Central Drugs Standard Control Organisation today recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covovax on children aged 2 to 17 years with certain conditions, sources said
-
BJP's New Plan To Shake Off COVID-19 Criticism
The BJP is set to start the second phase of a countrywide voluntary service to promote Covid vaccination, promote awareness and help people affected with the disease.
-
Covaxin Phase 2, 3 Clinical Trials For 2-18 Age Group Cleared
Covaxin trials on children from two to 18 years were cleared by the Drugs Controller General of India (DCGI) today. This is the first time in India that a Covid vaccine will be tested on children.
-
5 States, Union Territories Have No Private Facility For Covid Vaccine: Government Data
With the 3rd phase of COVID-19 vaccination opening in less than 2 weeks for everyone above 18, largely via private facilities, data shows almost all small states and union territories are still entirely or mostly dependent on government facilities.
-
Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report
Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
-
Covaxin Safe, Phase 3 Results Needed To Assess Effectiveness, Says Lancet
Covaxin, the homegrown coronavirus vaccine that was authorized for use in January before full clinical trial data, has been declared "safe, immunogenic with no serious side effects" by Lancet that has published its phase 2 results.
-
Getting A Covaxin Or Covishield Shot? List Of Possible Mild Side Effects
Phase 2 of the vaccination drive against the coronavirus - in which people aged above 60 and those above 45 with comorbidities are being inoculated - began on Monday.
-
Over 1 Million Registrations On CoWin For Phase 2 Vaccinations: 10 Points
Over a million people had registered on the government's CoWin portal by 1 pm today to get vaccinated against the coronavirus in the second phase of the country's inoculation drive. While the first phase of the vaccination campaign targeted healthcare and other frontline workers, the second phase that began today aims to inoculate those above 60 ye...
-
Odisha, Bihar Chief Ministers Take Vaccine Shots As India Begins Phase 2
Chief Ministers of Odisha and Bihar were among the beneficiaries as the second phase of the nationwide Covid vaccination began with Prime Minister Narendra Modi as the first beneficiary.
